These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31060487)

  • 1. Potential Roles of Siglecs in the Regulation of Allo-Immune Reaction.
    Cai S; Zhao J; Ueno T; Chandraker A
    Curr Protein Pept Sci; 2019; 20(8):823-828. PubMed ID: 31060487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Siglecs and immune regulation.
    Pillai S; Netravali IA; Cariappa A; Mattoo H
    Annu Rev Immunol; 2012; 30():357-92. PubMed ID: 22224769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialic Acid-Siglec Axis in Human Immune Regulation, Involvement in Autoimmunity and Cancer and Potential Therapeutic Treatments.
    Gianchecchi E; Arena A; Fierabracci A
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interplay between Siglecs and sialylated pathogens.
    Chang YC; Nizet V
    Glycobiology; 2014 Sep; 24(9):818-25. PubMed ID: 24996821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Siglecs at the Host-Pathogen Interface.
    Chang YC; Nizet V
    Adv Exp Med Biol; 2020; 1204():197-214. PubMed ID: 32152948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viewing Siglecs through the lens of tumor immunology.
    Fraschilla I; Pillai S
    Immunol Rev; 2017 Mar; 276(1):178-191. PubMed ID: 28258691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Siglecs as Immune Cell Checkpoints in Disease.
    Duan S; Paulson JC
    Annu Rev Immunol; 2020 Apr; 38():365-395. PubMed ID: 31986070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Sialic Acid-Binding Immunoglobulin-Type Lectins in Fish Reveals Teleost-Specific Structures and Expression Patterns.
    Bornhöfft KF; Martorell Ribera J; Viergutz T; Venuto MT; Gimsa U; Galuska SP; Rebl A
    Cells; 2020 Mar; 9(4):. PubMed ID: 32244286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
    Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
    J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-canonical roles of Siglecs: Beyond sialic acid-binding and immune cell modulation.
    Siddiqui SS
    Mol Aspects Med; 2023 Apr; 90():101145. PubMed ID: 36153172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Siglec-mediated regulation of immune cell function in disease.
    Macauley MS; Crocker PR; Paulson JC
    Nat Rev Immunol; 2014 Oct; 14(10):653-66. PubMed ID: 25234143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Siglecs on autoimmune diseases.
    Brzezicka KA; Paulson JC
    Mol Aspects Med; 2023 Apr; 90():101140. PubMed ID: 36055802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Status on Therapeutic Molecules Targeting Siglec Receptors.
    Lenza MP; Atxabal U; Oyenarte I; Jiménez-Barbero J; Ereño-Orbea J
    Cells; 2020 Dec; 9(12):. PubMed ID: 33333862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophil and mast cell Siglecs: From biology to drug target.
    O'Sullivan JA; Chang AT; Youngblood BA; Bochner BS
    J Leukoc Biol; 2020 Jul; 108(1):73-81. PubMed ID: 31965606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of the Siglec family in bone and bone homeostasis.
    Ye Z; Wang Y; Xiang B; Wang H; Tao H; Zhang C; Zhang S; Sun D; Luo F; Song L
    Biomed Pharmacother; 2023 Sep; 165():115064. PubMed ID: 37413904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensing the neuronal glycocalyx by glial sialic acid binding immunoglobulin-like lectins.
    Linnartz-Gerlach B; Mathews M; Neumann H
    Neuroscience; 2014 Sep; 275():113-24. PubMed ID: 24924144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural advances of Siglecs: insight into synthetic glycan ligands for immunomodulation.
    Movsisyan LD; Macauley MS
    Org Biomol Chem; 2020 Aug; 18(30):5784-5797. PubMed ID: 32756649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of innate and adaptive immunity on rejection and tolerance.
    Kim IK; Bedi DS; Denecke C; Ge X; Tullius SG
    Transplantation; 2008 Oct; 86(7):889-94. PubMed ID: 18852649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deacetylated sialic acids modulates immune mediated cytotoxicity via the sialic acid-Siglec pathway.
    Grabenstein S; Barnard KN; Anim M; Armoo A; Weichert WS; Bertozzi CR; Parrish CR; Willand-Charnley R
    Glycobiology; 2021 Nov; 31(10):1279-1294. PubMed ID: 34192335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans.
    Rosenstock P; Horstkorte R; Gnanapragassam VS; Harth J; Kielstein H
    Immunol Res; 2017 Oct; 65(5):1017-1024. PubMed ID: 28786023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.